scholarly journals A negative feedback loop of ICER and NF-κB regulates TLR signaling in innate immune responses

2016 ◽  
Vol 24 (3) ◽  
pp. 492-499 ◽  
Author(s):  
Sihan Lv ◽  
Jian Li ◽  
Xinchen Qiu ◽  
Weida Li ◽  
Chao Zhang ◽  
...  
2017 ◽  
Vol 36 (1) ◽  
pp. 1-9 ◽  
Author(s):  
Yuelong Ma ◽  
Li Zhang ◽  
Jie Lu ◽  
Tiejun Shui ◽  
Jia Chen ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Yamel Cardona Gloria ◽  
Stephan H. Bernhart ◽  
Sven Fillinger ◽  
Olaf-Oliver Wolz ◽  
Sabine Dickhöfer ◽  
...  

Gain-of-function mutations of the TLR adaptor and oncoprotein MyD88 drive B cell lymphomagenesis via sustained NF-κB activation. In myeloid cells, both short and sustained TLR activation and NF-κB activation lead to the induction of inhibitory MYD88 splice variants that restrain prolonged NF-κB activation. We therefore sought to investigate whether such a negative feedback loop exists in B cells. Analyzing MYD88 splice variants in normal B cells and different primary B cell malignancies, we observed that MYD88 splice variants in transformed B cells are dominated by the canonical, strongly NF-κB-activating isoform of MYD88 and contain at least three novel, so far uncharacterized signaling-competent splice isoforms. Sustained TLR stimulation in B cells unexpectedly reinforces splicing of NF-κB-promoting, canonical isoforms rather than the ‘MyD88s’, a negative regulatory isoform reported to be typically induced by TLRs in myeloid cells. This suggests that an essential negative feedback loop restricting TLR signaling in myeloid cells at the level of alternative splicing, is missing in B cells when they undergo proliferation, rendering B cells vulnerable to sustained NF-κB activation and eventual lymphomagenesis. Our results uncover MYD88 alternative splicing as an unappreciated promoter of B cell lymphomagenesis and provide a rationale why oncogenic MYD88 mutations are exclusively found in B cells.


2021 ◽  
Vol 18 (1) ◽  
Author(s):  
James A. Carroll ◽  
Brent Race ◽  
Katie Williams ◽  
James F. Striebel ◽  
Bruce Chesebro

Abstract Background Past experiments studying innate immunity in the central nervous system (CNS) utilized microglia obtained from neonatal mouse brain, which differ developmentally from adult microglia. These differences might impact our current understanding of the role of microglia in CNS development, function, and disease. Methods Cytokine protein secretion was compared in ex vivo P3 and adult microglial cultures after exposure to agonists for three different toll-like receptors (TLR4, lipopolysaccharide [LPS]; TLR7, imiquimod [IMQ]; and TLR9, CpG Oligodeoxynucleotide [CpG-ODN] 1585). In addition, changes in inflammatory gene expression in ex vivo adult microglia in response to the TLR agonists was assessed. Furthermore, in vivo experiments evaluated changes in gene expression associated with inflammation and TLR signaling in brains of mice with or without treatment with PLX5622 to reduce microglia. Results Ex vivo adult and P3 microglia increased cytokine secretion when exposed to TLR4 agonist LPS and to TLR7 agonist IMQ. However, adult microglia decreased expression of numerous genes after exposure to TLR 9 agonist CpG-ODN 1585. In contrast, in vivo studies indicated a core group of inflammatory and TLR signaling genes increased when each of the TLR agonists was introduced into the CNS. Reducing microglia in the brain led to decreased expression of various inflammatory and TLR signaling genes. Mice with reduced microglia showed extreme impairment in upregulation of genes after exposure to TLR7 agonist IMQ. Conclusions Cultured adult microglia were more reactive than P3 microglia to LPS or IMQ exposure. In vivo results indicated microglial influences on neuroinflammation were agonist specific, with responses to TLR7 agonist IMQ more dysregulated in mice with reduced microglia. Thus, TLR7-mediated innate immune responses in the CNS appeared more dependent on the presence of microglia. Furthermore, partial responses to TLR4 and TLR9 agonists in mice with reduced microglia suggested other cell types in the CNS can compensate for their absence.


2007 ◽  
Vol 179 (1) ◽  
pp. 514-521 ◽  
Author(s):  
Jong-Hwan Park ◽  
Yun-Gi Kim ◽  
Michael Shaw ◽  
Thirumala-Devi Kanneganti ◽  
Yukari Fujimoto ◽  
...  

2013 ◽  
Vol 23 (11) ◽  
pp. 1350180 ◽  
Author(s):  
JINYING TAN ◽  
XIUFEN ZOU

In this paper, we investigate the complex dynamical behaviors of a biological network that is derived from innate immune responses and that couples positive and negative feedback loops. The stability conditions of the non-negative equilibrium points (EPs) of the system are obtained, using the theory of dynamical systems, and we deduce that no more than three stable EPs exist in this system. Through bifurcation analysis and numerical simulations, we find that the system presents rich dynamical behaviors, such as monostability, bistability and oscillations. These results reveal how positive and negative feedback cooperatively regulate the dynamical behavior of the system.


mBio ◽  
2021 ◽  
Author(s):  
Mohammad Adnan Siddiqui ◽  
Masahiro Yamashita

Innate immune activation is a hallmark of HIV-1 pathogenesis. Thus, it is critical to understand how HIV-1 infection elicits innate immune responses.


2009 ◽  
Vol 184 (2) ◽  
pp. 956-964 ◽  
Author(s):  
Dola Sengupta ◽  
Alicia Koblansky ◽  
Jennifer Gaines ◽  
Tim Brown ◽  
A. Phillip West ◽  
...  

2005 ◽  
Vol 175 (7) ◽  
pp. 4320-4330 ◽  
Author(s):  
Carolyn S. Jack ◽  
Nathalie Arbour ◽  
Joshua Manusow ◽  
Vivianne Montgrain ◽  
Manon Blain ◽  
...  

2020 ◽  
Author(s):  
Yamel Cardona Gloria ◽  
Stephan H. Bernhart ◽  
Sven Fillinger ◽  
Olaf-Oliver Wolz ◽  
Sabine Dickhöfer ◽  
...  

AbstractGain-of-function mutations of the TLR adaptor and oncoprotein MyD88 drive B cell lymphomagenesis via sustained NF-κB activation. In myeloid cells, sustained TLR activation and NF-κB activation lead to the induction of inhibitory MYD88 splice variants that restrain prolonged NF-κB activation. We therefore sought to investigate whether such a negative feedback loop exists in B cells. Analyzing MYD88 splice variants in normal B cells and different primary B cell malignancies, we observed that MYD88 splice variants in transformed B cells are dominated by the canonical, strongly NF-κB-activating isoform of MYD88 and contain at least three novel, so far uncharacterized signaling-competent splice isoforms. TLR stimulation in B cells unexpectedly reinforces splicing of NF-κB-promoting, canonical isoforms rather than the ‘MyD88s’, a negative regulatory isoform that is typically induced by TLRs in myeloid cells. This suggests that an essential negative feedback loop restricting TLR signaling in myeloid cells at the level of alternative splicing, is missing in B cells, rendering B cells vulnerable to sustained NF-κB activation and eventual lymphomagenesis. Our results uncover MYD88 alternative splicing as an unappreciated promoter of B cell lymphomagenesis and provide a rationale why oncogenic MYD88 mutations are exclusively found in B cells.


Sign in / Sign up

Export Citation Format

Share Document